top of page
Systemic Therapeutics Logo

Systemic Therapeutics Corp. is a Canadian pre-clinical stage, biotechnology company specialized in the development of new therapies focusing on the master regulator of lipid metabolism, sterol regulatory-element binding proteins (SREBP), based on first-in-class small molecule SREBP inhibitors. The Company aims to provide new treatment options for metabolic conditions such as dyslipidemia, via reduction of circulating PCSK9, and Non-Alcoholic Fatty Liver Disease.

We are pioneering a new approach to the care of metabolic disorders

with first-in-class small molecule SREBP inhibitors.

A Novel Paradigm for Metabolic Disorders.

Image by Scott Webb



Richard C. Austin, BSc MSc PhD

Co-Founder, Executive Chairman and Chief Scientific Officer

Mark Tarnopolsky, MD PhD FRCPC

Co-Founder and Vice President,

Business Development

Guillaume Paré, MD MSc FRCPC

Co-Founder and Chief Medical Officer

Jakob Magolan, PhD

Co-Founder and Vice President,

Drug Discovery

Latest News

bottom of page